FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1914710688> ?p ?o ?g. }

• W1914710688 endingPage "40080" @default.
• W1914710688 startingPage "40068" @default.
• W1914710688 abstract "// Yang Bu 1, 2, * , Qing-An Jia 3, * , Zheng-Gang Ren 2, * , Tong-Chun Xue 2 , Quan-Bao Zhang 2 , Ke-Zhi Zhang 2 , Qiang-Bo Zhang 2 , Yang You 2 , Hui Tian 2 , Lun-Xiu Qin 3 , Zhao-You Tang 2 1 Hepatobiliary Surgery, General Hospital of Ningxia Medical University, Yinchuan 750001, China 2 Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai 200032, China 3 Cancer Center, Institutes of Biomedical Sciences, General Surgery, Huashan Hospital, Fudan University, Shanghai 200032, China * These authors have contributed equally to this work Correspondence to: Zhao-You Tang, e-mail: zytang88@163.com Keywords: Songyou Yin, hepatocellular carcinoma, chronic fibrosis, activated hepatic stellate cells Received: April 08, 2014      Accepted: October 09, 2015      Published: October 22, 2015 ABSTRACT Chronic fibrosis is a major risk factor for the development of hepatocellular carcinoma (HCC). The pathological progression of hepatic fibrosis has been linked to cellular processes that promote tumor growth and metastasis. Several recent studies have highlighted the cross-talk between tumor cells and activated hepatic stellate cells (aHSCs) in HCC. The herbal compound Songyou Yin (SYY) is known to attenuate hepatoma cell invasion and metastasis via down-regulation of cytokine secretion by aHSCs. However the underlying mechanism of SYY treatment in reversal of hepatic fibrosis and metastasis of liver cancers is not known. In the current study, a nude mouse model with liver fibrosis bearing orthotopic xenograft was established and we found that SYY could reduce associated fibrosis, inhibit tumor growth and improve survival. In the subcutaneous tumor model with fibrosis, we found that SYY could inhibit liver cancer. In vitro , hepatoma cells incubated with conditioned media (CM) from SYY treated aHSCs showed reduced proliferation, decrease in colony formation and invasive potential. SYY treated group showed altered gene expression, with 1205 genes up-regulated and 1323 genes down-regulated. Gene cluster analysis indicated that phosphatidylinositol-3-kinase (PI3K) was one of the key genes altered in the expression profiles. PI3K related markers were all significantly down-regulated. ELISA also indicated decreased secretion of cytokines which were regulated by PI3K/AKT signaling after SYY treatment in the hepatic stellate cell line, LX2. These data clearly demonstrate that SYY therapy inhibits HCC invasive and metastatic potential and improves survival in nude mice models with chronic fibrosis background via inhibition of cytokine secretion by activated hepatic stellate cells." @default.
• W1914710688 created "2016-06-24" @default.
• W1914710688 creator A5003345307 @default.
• W1914710688 creator A5031852092 @default.
• W1914710688 creator A5037621061 @default.
• W1914710688 creator A5040576397 @default.
• W1914710688 creator A5046502823 @default.
• W1914710688 creator A5050208449 @default.
• W1914710688 creator A5056338205 @default.
• W1914710688 creator A5063254439 @default.
• W1914710688 creator A5077196517 @default.
• W1914710688 creator A5081595540 @default.
• W1914710688 creator A5088091238 @default.
• W1914710688 date "2015-10-22" @default.
• W1914710688 modified "2023-10-18" @default.
• W1914710688 title "The herbal compound Songyou Yin (SYY) inhibits hepatocellular carcinoma growth and improves survival in models of chronic fibrosis via paracrine inhibition of activated hepatic stellate cells" @default.
• W1914710688 cites W1749733472 @default.
• W1914710688 cites W1906235443 @default.
• W1914710688 cites W1964926602 @default.
• W1914710688 cites W1966689397 @default.
• W1914710688 cites W1973554995 @default.
• W1914710688 cites W1980325398 @default.
• W1914710688 cites W1989025666 @default.
• W1914710688 cites W2008936830 @default.
• W1914710688 cites W2012124753 @default.
• W1914710688 cites W2015052618 @default.
• W1914710688 cites W2018320453 @default.
• W1914710688 cites W2028850312 @default.
• W1914710688 cites W2041326302 @default.
• W1914710688 cites W2044158827 @default.
• W1914710688 cites W2049584121 @default.
• W1914710688 cites W2051628687 @default.
• W1914710688 cites W205217678 @default.
• W1914710688 cites W2055374350 @default.
• W1914710688 cites W2056446343 @default.
• W1914710688 cites W2059768085 @default.
• W1914710688 cites W2062809449 @default.
• W1914710688 cites W2076348865 @default.
• W1914710688 cites W2082503761 @default.
• W1914710688 cites W2083142606 @default.
• W1914710688 cites W2087590639 @default.
• W1914710688 cites W2088629624 @default.
• W1914710688 cites W2089956125 @default.
• W1914710688 cites W2095792786 @default.
• W1914710688 cites W2100121019 @default.
• W1914710688 cites W2102026582 @default.
• W1914710688 cites W2106787323 @default.
• W1914710688 cites W2112384360 @default.
• W1914710688 cites W2115023106 @default.
• W1914710688 cites W2118614921 @default.
• W1914710688 cites W2121411068 @default.
• W1914710688 cites W2122136471 @default.
• W1914710688 cites W2146934451 @default.
• W1914710688 cites W2149188297 @default.
• W1914710688 cites W2154239359 @default.
• W1914710688 cites W2162996662 @default.
• W1914710688 cites W2165989705 @default.
• W1914710688 cites W2168959203 @default.
• W1914710688 cites W4234752386 @default.
• W1914710688 doi "https://doi.org/10.18632/oncotarget.5313" @default.
• W1914710688 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4741880" @default.
• W1914710688 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26517671" @default.
• W1914710688 hasPublicationYear "2015" @default.
• W1914710688 type Work @default.
• W1914710688 sameAs 1914710688 @default.
• W1914710688 citedByCount "11" @default.
• W1914710688 countsByYear W19147106882016 @default.
• W1914710688 countsByYear W19147106882017 @default.
• W1914710688 countsByYear W19147106882018 @default.
• W1914710688 countsByYear W19147106882019 @default.
• W1914710688 countsByYear W19147106882020 @default.
• W1914710688 countsByYear W19147106882021 @default.
• W1914710688 countsByYear W19147106882022 @default.
• W1914710688 crossrefType "journal-article" @default.
• W1914710688 hasAuthorship W1914710688A5003345307 @default.
• W1914710688 hasAuthorship W1914710688A5031852092 @default.
• W1914710688 hasAuthorship W1914710688A5037621061 @default.
• W1914710688 hasAuthorship W1914710688A5040576397 @default.
• W1914710688 hasAuthorship W1914710688A5046502823 @default.
• W1914710688 hasAuthorship W1914710688A5050208449 @default.
• W1914710688 hasAuthorship W1914710688A5056338205 @default.
• W1914710688 hasAuthorship W1914710688A5063254439 @default.
• W1914710688 hasAuthorship W1914710688A5077196517 @default.
• W1914710688 hasAuthorship W1914710688A5081595540 @default.
• W1914710688 hasAuthorship W1914710688A5088091238 @default.
• W1914710688 hasBestOaLocation W19147106881 @default.
• W1914710688 hasConcept C121608353 @default.
• W1914710688 hasConcept C126322002 @default.
• W1914710688 hasConcept C142724271 @default.
• W1914710688 hasConcept C143998085 @default.
• W1914710688 hasConcept C176891718 @default.
• W1914710688 hasConcept C2776231280 @default.
• W1914710688 hasConcept C2778019345 @default.
• W1914710688 hasConcept C2779013556 @default.
• W1914710688 hasConcept C2780559512 @default.
• W1914710688 hasConcept C2993667909 @default.
• W1914710688 hasConcept C502942594 @default.
• W1914710688 hasConcept C555283112 @default.

• next